Back to search

Article

Mass-Standardised Quantitative Measurements of the Antibody Levels for SARS-CoV-2 beyond Correlates of Protection and Clearance

2022-07-15

Abstract excerpt

A quantitative biophotonic assay for IgG antibodies for the SARS-CoV-2 spike protein has been standardised against the NISTmAb antibody. Serum from patients recovering from infection, a sterilising serum, and post-vaccination, are used to profile anti-spike protein IgG responses. The vaccine response distributions were used to quantify live-challenge protective thresholds: the 31 st percentile of the AstraZeneca...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6cd908b5-0247-5d09-b6dd-eb5ea8eaa8bb
DOI
10.1101/2022.07.12.22277533
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Mass-Standardised Quantitative Measurements of the Antibody Levels for SARS-CoV-2 beyond Correlates of Protection and ClearanceDOI 10.1101/2022.07.12.22277533
Fully Quantitative Measurements of Differential Antibody Binding to a Spectrum of SARS-CoV-2 Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4, BA.5, BA.2.75 and BA.2.12.1Semantic proximity
Robust correlations across six SARS‐CoV‐2 serology assays detecting distinct antibody featuresSemantic proximity
Towards Internationally standardised humoral Immune Correlates of Protection from SARS-CoV-2 infection and COVID-19 diseaseSemantic proximity
Detection and Quantification of Antibody to SARS-CoV-2 Receptor Binding Domain Provides Enhanced Sensitivity, Specificity and UtilitySemantic proximity
Development and Validation of Novel Cell-free Direct Neutralization Assay for SARS-CoV-2Semantic proximity
Mass-Standardised Differential Antibody Binding to a Spectrum of SARS-CoV-2 Variant Spike Proteins: Wuhan, Alpha, Beta, Gamma, Delta, Omicron BA.1, BA.4/5, BA.2.75 and BA.2.12.1 variants - Antibody Immunity EndotypesSemantic proximity
Quantifying post-vaccination protective anti-SARS-CoV-2 IgG antibodies in blood and saliva with a fully automated, high throughput digital immunoassaySemantic proximity
Anti-SARS-CoV-2 antibody levels are concordant across multiple platforms but are not fully predictive of sterilizing immunitySemantic proximity
IMMUNO-COV™ v2.0: Development and Validation of a High-Throughput Clinical Assay for Measuring SARS-CoV-2-Neutralizing Antibody TitersSemantic proximity
Quantitative, multiplexed, targeted proteomics for ascertaining variant specific SARS-CoV-2 antibody responseSemantic proximity
Emergency Response for Evaluating SARS-CoV-2 Immune Status, Seroprevalence and Convalescent Plasma in ArgentinaSemantic proximity
Neutralisation hierarchy of SARS-CoV-2 Variants of Concern using standardised, quantitative neutralisation assays reveals a correlation with disease severity; towards deciphering protective antibody thresholdsSemantic proximity
Select a neighboring publication to make it the new centre.